Corbus Pharmaceuticals Holdings (CRBP) Payables (2013 - 2025)

Corbus Pharmaceuticals Holdings has reported Payables for 13 years, with the latest figure at $2.2 million in Q4 2025.

• On a quarterly basis, Payables fell 53.72% year-over-year to $2.2 million in Q4 2025; TTM through Dec 2025 was $2.2 million, a 53.72% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 53.72% from the prior year.
• Payables was $2.2 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $2.7 million in the prior quarter.
• The five-year high for Payables was $4.8 million in Q4 2024, with the low at $1.2 million in Q2 2024.
• Average Payables over 5 years is $2.8 million, with a median of $2.6 million recorded in 2021.
• The sharpest annual moves came in 2021 and 2025: Payables slumped 80.66% in 2021, then surged 224.49% in 2025.
• Over 5 years, Payables stood at $2.6 million in 2021, then dropped by 0.9% to $2.5 million in 2022, then surged by 37.7% to $3.5 million in 2023, then jumped by 37.53% to $4.8 million in 2024, then slumped by 53.72% to $2.2 million in 2025.
• The last three Payables figures came in at $2.2 million (Q4 2025), $2.7 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.